What is circulating tumor DNA and how is it used to diagnose and manage cancer?
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Circulating tumour DNA (ctDNA) is found in the bloodstream and refers to DNA that comes from cancerous cells and tumours. Most DNA is inside a cell’s nucleus. As a tumour grows, cells die and are replaced by new ones. The dead cells get broken down and their contents, including DNA, are released into the bloodstream. ctDNA are small pieces of DNA, usually comprising fewer than 200 building blocks (nucleotides) in length.
Videoval för Understanding geneticsVideobibliotek
Översikt
Circulating tumour DNA (ctDNA) is found in the bloodstream and refers to DNA that comes from cancerous cells and tumours. Most DNA is inside a cell’s nucleus. As a tumour grows, cells die and are replaced by new ones. The dead cells get broken down and their contents, including DNA, are released into the bloodstream. ctDNA are small pieces of DNA, usually comprising fewer than 200 building blocks (nucleotides) in length.
The quantity of ctDNA varies among individuals and depends on the type of tumour, its location, and for cancerous tumours, the cancer stage.
Detection of ctDNA can be helpful in the following cases:
Detecting and diagnosing a tumour. Because tumour DNA has acquired multiple genetic changes (variants), leading to tumour development, ctDNA is not an exact match to the individual’s DNA. Finding DNA with genetic differences aids in tumour detection. Diagnosing the type of tumour using ctDNA can reduce the need for getting a sample of the tumour tissue (tumour biopsy), which can be challenging when a tumour is difficult to access, such as a tumour in the brain or lung.
Guiding tumour-specific treatment. Analyzing the genome of tumour cells using ctDNA can help doctors determine which treatment will be most effective. Currently, however, approval from the U.S. Food and Drug Administration for ctDNA testing to personalize cancer treatment is limited.
Monitoring treatment. A decrease in the quantity of ctDNA suggests the tumour is shrinking and treatment is successful.
Monitoring periods with no symptoms (remission of cancer). A lack of ctDNA in the bloodstream indicates that the cancer has not returned.
Related patient information and medicines

Patient information leaflet
Orsaker till cancer
Different parts of the body such as organs, bones, muscles, skin and blood are made up from different specialised cells. Most cells have a centre called a nucleus. The nucleus in each cell contains thousands of genes which are made up från a chemical called DNA. The genes are like codes which control the functions of the cell. For example,.

Patient information leaflet
Diagnostisera cancer
You may be referred for tests such as X-rays X-ray test , scans, blood tests Blood tes... These tests can often find the site of a suspected cancer. However, a sample (biopsy) is often needed to be certain that the abnormality is a cancer and not something else - such as a non-cancerous (benign) tumour. Biopsy A biopsy Biopsy is a procedure where.

Patient information leaflet
Cancer
Cancer is a disease of the cells in the body. There are many different types of cells in the body, and many different types of cancer which arise from different types of cells. What is cancer. Cancer occurs when cells become abnormal and multiply out of control. Different cells in the different parts of the body when multiplied cause different.

Patient information leaflet
Retinoblastom
Retinoblastoma is an uncommon cancer of the eye which occurs in children under the age of 5. It discusses the symptoms and signs of retinoblastoma and the management options children with retinoblastoma may be offered. What causes retinoblastoma. Retinoblastoma is a genetic disease. Genetisk diseases are disorders of the 46 chromosomes which.

Patient information leaflet
Hjärntumörer
This leaflet aims to give a brief overview of the various types of brain tumours. The treatment and survival rates vary greatly, depending on factors such as the type of tumour and the location in the brain. This is divided into the right side (right hemisphere) which controls the left side of the body, and the left hemisphere which controls the.

Patient information leaflet
Malignt melanom
Melanoma (also called malignant melanoma) is the most serious type of skin cancer. The treatment for melanoma is mainly surgical but other treatments, including chemotherapy and radiotherapy, are increasingly used, especially if it is not possible to remove all the melanoma or if the melanoma is diagnosed at a relatively late stage. How common is.
Vidare läsning och referenser
- What is circulating tumor DNA and how is it used to diagnose and manage cancer?; MedlinePlus, National Library of Medicine.
- Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, Hayes DF, Turner NC. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. J Clin Oncol. 2018 Jun 1;36(16):1631-1641. doi: 10.1200/JCO.2017.76.8671. Epub 2018 Mar 5. PubMed: 29504847.
- Stewart CM, Kothari PD, Mouliere F, Mair R, Somnay S, Benayed R, Zehir A, Weigelt B, Dawson SJ, Arcila ME, Berger MF, Tsui DW. The value of cell-free DNA for molecular pathology. J Pathol. 2018 Apr;244(5):616-627. doi: 10.1002/path.5048. Epub 2018 Mar 12. PubMed: 29380875.
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

